This is a firm-fixed-price purchase order contract awarded by the National Institute on Aging (NIA), a civilian federal agency, to the National University of Singapore (NUS) for $149,450.40. The contract is for testing the efficacy of candidate Alzheimer's disease treatments in rescuing impaired hippocampal synaptic plasticity. The contract does not have a set-aside designation. NUS is an international research institution with extensive expertise in advanced scientific research, including...
This is a $199,812 firm fixed price purchase order awarded by the National Institutes of Health's (NIH) National Institute on Aging (NIA) to QPS Austria GMBH, a contract research organization. The contract is for in vivo efficacy studies of a candidate Alzheimer's treatment in a transgenic mouse model. This award is part of the NIA's Drug Repurposing for Effective Alzheimer's Medicines (DREAM) study, which aims to identify FDA-approved drugs that may be repurposed as disease-modifying...
The Department of Health and Human Services' National Institutes of Health National Institute on Aging awarded a $298,624 firm fixed-price purchase order to QPS Austria GmbH to provide phenotypic screening services to identify effective treatments for Alzheimer's disease. The requirement, as outlined in the solicitation, is for the contractor to test approximately 20 FDA-approved drugs that have been nominated as potential treatments in order to determine if exposure is associated with lower...
This is a $249,334 firm fixed-price purchase order awarded by the National Institute on Aging (NIA) to Scantox Neuro GMBH, a for-profit organization based in Austria. The contract supports pharmacodynamic and tolerability studies of candidate Alzheimer's disease (AD) drugs using a transgenic AD mouse model. This work builds on NIA's ongoing efforts under the Drug Repurposing for Effective Alzheimer's Medicines (DREAM) and Experimental Validation of Candidate Alzheimer's Disease Treatments...
The National Institute on Aging (NIA), part of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), awarded an $852,000 firm fixed price delivery order contract to The Bioteam, Inc. (Bioteam) under the company's Multiple Award Schedule contract vehicle. Bioteam will perform an Alzheimer's Disease (AD) and Alzheimer's Disease-Related Dementias (ADRD) Data Ecosystem Landscape Assessment for NIA through November 15, 2023 from its place of performance...
This is a $1,485,008.40, firm-fixed-price contract awarded by the National Institute on Drug Abuse (NIDA), on behalf of the National Institute of Neurological Disorders and Stroke (NINDS), to Curia Global Inc. (doing business as Amri). The contract is for the non-GMP synthesis of up to 100 compounds in 2-10 milligram quantities to support a medicinal chemistry discovery program focused on identifying molecules that bind the KIAA0203 protein, which could potentially lead to the development of a...
The National Institutes of Health, an agency of the Department of Health and Human Services, awarded a $793,492 delivery order contract to the National Academy of Sciences to develop a behavioral and social science research agenda on Alzheimer's disease and related dementias. The cost-no-fee contract runs from September 2018 through December 2020 in Washington, D.C. and calls for the prime contractor, the National Academy of Sciences, to deliver products and services to establish a research...
The National Institutes of Health (NIH) Intramural Center for Alzheimer's and Related Dementias (CARD) awarded a $1,358,471.01 firm-fixed-price purchase order to Government Scientific Source Inc. for a High-Content Screening System (Opera Phenix Plus or equivalent). This equipment will support the Induced Pluripotent Stem Cell Neurodegenerative Disease Initiative (iNDI) project, which aims to measure how neurodegeneration-related mutations alter protein networks in disease-relevant cell...
The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a $24,885.10 purchase order to The Johns Hopkins University for laboratory and testing services - neuropsychometric evaluations. The contract has a period of performance from September 30, 2023 through September 29, 2024 and utilizes a firm fixed price pricing structure. The place of performance will be Baltimore, Maryland. No set aside designation or subcontractors were indicated. The...
The National Institutes of Health (NIH), an agency of the Department of Health and Human Services (HHS), awarded a $550,000 cost-no-fee delivery order contract to the National Academy of Sciences (NAS) to support research related to Alzheimer's disease over an 18-month period ending January 2022. The place of performance will be NAS offices in Washington, D.C. This delivery order was issued against an existing NIH logistics and acquisition vehicle and will allow NAS to provide advisory and...
This is a firm fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Aging to the National University of Singapore. The $169,830 contract is for testing the efficacy of candidate Alzheimer's disease treatments in rescuing impaired hippocampal synaptic plasticity. This is part of the NIH's Drug Repurposing for Effective Alzheimer's Medicines (DREAM) study, which is testing approximately 20 FDA-approved drugs to identify potential disease-modifying treatments for Alzheimer's disease. The contract, which has a completion date of March 29, 2025, does not have a set-aside designation.